CKX vs JNJ · P/E 28, rev $339.0K vs P/E 17, rev $49.37B
CKX Lands Inc (CKX) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
CKX Lands Inc (CKX) is a oil & gas e&p company listed on US.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported CKX revenue for 2026-06-30 was $339.0K. Net income was $177.5K. Revenue was up 98.6% from 2026-03-31 to 2026-06-30. CKX currently screens at market cap $22.2M and trailing P/E 28.2.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
CKX currently screens at market cap $22.2M and trailing P/E 28.2. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the CKX and JNJ stock pages for the full models.
Not investment advice.